Kukje Pharma Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kukje Pharma Co Ltd with three other
companies in this sector in South Korea:
Daehwa Pharmaceutical Company Limited
sales of 110.14 billion Korean Won [US$96.48 million]
of which 73%
was Medicine Mafufacture),
HLB Life Science Co Ltd
(102.48 billion Korean Won [US$89.77 million]
of which 94%
was Distribution Industry), and
Binex Company Ltd
(104.04 billion Korean Won [US$91.14 million]
of which 71%
Kukje Pharma Co Ltd reported sales of 107.68 billion Korean Won (US$94.33 million)
December of 2018.
decrease of 12.7%
versus 2017, when the company's sales were 123.31 billion Korean Won.
Contributing to the drop in overall sales was the 90.3% decline
in Cosmetics, from 8.60 billion Korean Won to 833.74 million Korean Won.
There were also decreases in sales in
Pharmaceutical (down 7.2% to 105.47 billion Korean Won)
However, these declines were partially offset by the increase in sales of
Other Segment (up 34.9% to 1.38 billion Korean Won)